Aeterna Zentaris Stock Price - AEZS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Aeterna Zentaris Inc AEZS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 1.79 0.00 0.00 0.00 1.79 03:59:46
Bid Price Ask Price Spread Spread % News
1.77 3.96 2.19 55.30% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Aeterna Zentaris Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 29.77M 16.63M $ 4.19M 0.25 - 16.44M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Aeterna Zentaris News

Loading Messages....

Latest AEZS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AEZS Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week1.761.931.761.827365k0.031.70%
1 Month2.082.571.761.9868102k-0.29-13.94%
3 Months2.693.061.762.312784k-0.9-33.46%
6 Months3.995.58691.763.5598161k-2.2-55.14%
1 Year1.615.58691.293.0606319k0.1811.18%
3 Years3.365.590.78162.5593540k-1.57-46.73%
5 Years1451450.781614.75362M-143.21-98.77%

Aeterna Zentaris Description

AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.


Your Recent History
NASDAQ
AEZS
Aeterna Ze..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.